Biotech / Gene Therapy
Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety
Sarepta Therapeutics is taking proactive steps to address safety concerns regarding ELEVIDYS, its gene therapy for Duchenne muscular dystrophy, following reports of acute liver failure in non-ambulatory patients. The company is working with...